Hybrid Coronary Revascularization as a Safe, Feasible, and Viable Alternative to Conventional Coronary Artery Bypass Grafting: What Is the Current Evidence?

Table 5

Comparison of hospital outcomes.

Outcome	de Cannière et al. [12]		Kon et al. [7]		Halkos et al. [27]		Hu et al. [28]
	Hybrid; (𝑛 = 20); Mean ± SD or no. (%)	CABG; (𝑛 = 20); Mean ± SD or no. (%)	Hybrid; (𝑛 = 15); Mean ± SD or no. (%)	OPCAB; (𝑛 = 30); Mean ± SD or no. (%)	Hybrid; (𝑛 = 147); Mean ± SD or no. (%)	OPCAB; (𝑛 = 588); Mean ± SD or no. (%)	Hybrid; (𝑛 = 104); Mean ± SD or no. (%)	OPCAB; (𝑛 = 104); Mean ± SD or no. (%)
Hospital LOS (days)	6.7 ± 0.7*	9.0 ± 1.2*	3.7 ± 1.4**	6.4 ± 2.2**	6.6 ± 6.7	6.1 ± 4.7	8.2 ± 2.6*	9.5 ± 4.5*
ICU LOS (hours)	20.2 ± 1.8*	26.6 ± 11.2*	23.5 ± 10.1**	58.1 ± 37.7**	57.4 ± 145.0	52.7 ± 87.8	34.5 ± 35.6**	55.3 ± 46.4**
Intubation time (hours)	NR	NR	1.3 ± 3.4**	20.6 ± 25.7**	17.0 ± 30.8	22.7 ± 89.5	11.6 ± 6.3*	13.8 ± 6.8*
PRBC transfusion	0 (0.0)	4 (20.0)	NR	NR	52 (34.4)**	329 (56.0)**	30 (28.8)**	54 (51.9)**
In-hospital MACCE	0 (0.0)	2 (10.0)	0 (0.0)*	7 (23.3)*	3 (2.0)	12 (2.0)	0 (0.0)	0 (0.0)
Death	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (0.7)	5 (0.9)	0 (0.0)	0 (0.0)
Stroke	0 (0.0)	0 (0.0)	0 (0.0)	1 (3.3)	1 (0.7)	4 (0.7)	0 (0.0)	0 (0.0)
MI	0 (0.0)	2 (10.0)	0 (0.0)	6 (20.0)	1 (0.7)	3 (0.5)	0 (0.0)	0 (0.0)
Conclusion	Favours hybrid		Favours hybrid		Favours hybrid		Favours hybrid

∗P value <0.05.
∗∗P value <0.005.
CABG: coronary artery bypass grafting; OPCAB: off-pump coronary artery bypass; SD: standard deviation; LOS: length of stay; ICU: intensive care unit; NR: not reported; PRBC: packed red blood cells; MACCE: major adverse cardiac and cerebrovascular events; MI: myocardial infarction.